Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
Clinical Pharmacokinetics|December 20, 1999
Population pharmacokinetics of continuous infusion ceftazidimeB C Frame, B F Facca, D P Nicolau, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1997
Once-daily dosing of aminoglycosides: review and recommendations for clinical practiceC D Freeman, D P Nicolau, P P Belliveau, et al.
Chemotherapy|July 8, 1999
Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection modelP R Tessier, D P Nicolau, C O Onyeji, et al.
Clinical Pharmacokinetics|July 1, 1993
Lomefloxacin clinical pharmacokineticsC D Freeman, D P Nicolau, P P Belliveau, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2012
Comparative efficacies of human simulated exposures of tedizolid and linezolid against Staphylococcus aureus in the murine thigh infection modelR A Keel, P R Tessier, J L Crandon, et al.
The Journal of Hospital Infection|January 22, 2016
Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infectionA K Thabit, S T Housman, C D Burnham, et al.
Anaesthesia and Intensive Care|March 16, 2012
Performance of the PIRO score for predicting mortality in patients with ventilator-associated pneumoniaG H Furtado, D E Wiskirchen, J L Kuti, et al.
Laboratory Animal Science|February 1, 1995
Disposition kinetics of aspirin in female New Zealand white rabbitsM N Marangos, C O Onyeji, D P Nicolau, et al.
The Journal of Burn Care & Rehabilitation|May 1, 1994
The costs of burn care: an analysis with an emphasis on the use of parenteral antimicrobialsD P Nicolau, R L White, L V Friedrich, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2007
Addressing resistance evolution in Pseudomonas aeruginosa using pharmacodynamic modelling: application to meropenem dosage and combination therapyL Santos Filho, K J Eagye, J L Kuti, et al.
Pageof 19